- Home
- PRAX vs FWRD Comparison
PRAX vs FWRD Comparison
Compare PRAX & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- FWRD
- Stock Information
- Founded
- PRAX 2015
- FWRD 1981
- Country
- PRAX United States
- FWRD United States
- Employees
- PRAX N/A
- FWRD N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- FWRD Oil Refining/Marketing
- Sector
- PRAX Health Care
- FWRD Consumer Discretionary
- Exchange
- PRAX Nasdaq
- FWRD Nasdaq
- Market Cap
- PRAX 599.7M
- FWRD 634.2M
- IPO Year
- PRAX 2020
- FWRD 1993
- Fundamental
- Price
- PRAX $38.35
- FWRD $16.32
- Analyst Decision
- PRAX Strong Buy
- FWRD Hold
- Analyst Count
- PRAX 10
- FWRD 5
- Target Price
- PRAX $116.50
- FWRD $27.33
- AVG Volume (30 Days)
- PRAX 430.8K
- FWRD 748.9K
- Earning Date
- PRAX 05-02-2025
- FWRD 05-07-2025
- Dividend Yield
- PRAX N/A
- FWRD N/A
- EPS Growth
- PRAX N/A
- FWRD N/A
- EPS
- PRAX N/A
- FWRD N/A
- Revenue
- PRAX $8,122,000.00
- FWRD $2,545,730,000.00
- Revenue This Year
- PRAX N/A
- FWRD $8.76
- Revenue Next Year
- PRAX $789.73
- FWRD $7.28
- P/E Ratio
- PRAX N/A
- FWRD N/A
- Revenue Growth
- PRAX 270.02
- FWRD 63.73
- 52 Week Low
- PRAX $26.70
- FWRD $9.79
- 52 Week High
- PRAX $91.83
- FWRD $40.92
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- FWRD 48.34
- Support Level
- PRAX $34.89
- FWRD $16.22
- Resistance Level
- PRAX $40.89
- FWRD $19.10
- Average True Range (ATR)
- PRAX 2.30
- FWRD 1.26
- MACD
- PRAX 0.70
- FWRD 0.45
- Stochastic Oscillator
- PRAX 57.95
- FWRD 49.36
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight and Intermodal. The company generates maximum revenue from the Expedited Freight segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.